Geneva University Hospitals

Year	Article	Times Cited	Times Cited (no self-citations)
2016	Langdahl B, Ferrari S, Dempster DW. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskel Dis. December 2016;8(6):225-235.	13	12
2020	Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, Wang A, Pannacciulli N, Cummings SR. Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension. Bone. May 2020;134:115268.	1	0
2020	Ferrari S, Lewiecki EM, Butler PW, Kendler DL, Napoli N, Huang S, Crittenden DB, Pannacciulli N, Siris E, Binkley N. Favorable skeletal benefit/risk of long-term denosumab therapy: a virtual-twin analysis of fractures prevented relative to skeletal safety events observed. Bone. May 2020;134:115287.	0	0
2020	Papageorgiou M, Föger-Samwald U, Wahl K, Kerschan-Schindl K, Pietschmann P. Age- and strain-related differences in bone microstructure and body composition during development in inbred male mouse strains. Calcif Tiss Int. April 2020;106(4):431-443.	0	0
2020	Cardinal M, Dessain A, Roels T, Lafont S, Ominsky MS, Devogelaer J-P, Chappard D, Mabilleau G, Ammann P, Nyssen-Behets C, Manicourt DH. Sclerostin-antibody treatment decreases fracture rates in axial skeleton and improves the skeletal phenotype in growing oim/oim mice. Calcif Tiss Int. May 2020;106(5):494-508.	1	1
2020	Chevalier C, Kieser S, Çolakoğlu M, Hadadi N, Brun J, Rigo D, Suárez-Zamorano N, Spiljar M, Fabbiano S, Busse B, Ivanišević J, Macpherson A, Bonnet N, Trajkovski M. Warmth prevents bone loss through the gut microbiota. Cell Metab. October 6, 2020;32(4):575.	0	0
1999	Farshad M, Barbezat M, Flüeler P, Schmidlin F, Graber P, Niederer P. Material characterization of the pig kidney in relation with the biomechanical analysis of renal trauma. J Biomech. April 1999;32(4):417-425.	12	10
2005	Snedeker JG, Barbezat M, Niederer P, Schmidlin FR, Farshad M. Strain energy density as a rupture criterion for the kidney: impact tests on porcine organs, finite element simulation, and a baseline comparison between human and porcine tissues. J Biomech. May 2005;38(5):993-1001.	12	11
2005	Snedeker JG, Niederer P, Schmidlin FR, Farshad M, Demetropoulos CK, Lee JB, Yang KH. Strain-rate dependent material properties of the porcine and human kidney capsule. J Biomech. May 2005;38(5):1011-1021.	14	9
2020	Ferrari S. Zoledronate following denosumab discontinuation: partial reassurance but no confidence. J Bone Miner Res. July 2020;35(7):1205-1206.	0	0
2020	Cosman F, Lewiecki EM, Ebeling PR, Hesse E, Napoli N, Matsumoto T, Crittenden DB, Rojeski M, Yang W, Libanati C, Ferrari S. T‐score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial. J Bone Miner Res. July 2020;35(7):1333-1342.	1	1
2021	Gerbaix M, Ammann P, Ferrari S. Mechanically driven counter‐regulation of cortical bone formation in response to sclerostin‐neutralizing antibodies. J Bone Miner Res. February 2021;36(2):385-399.	0	0
2019	Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, Liu C-T, Lorentzon M, Mellstrom D, Merle B, Nethander M, Rizzoli R, Sornay-Rendu E, Van Rietbergen B, Sundh D, Wong AKO, Ohlsson C, Demissie S, Kiel DP, Bouxsein ML. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. January 2019;7(1):34-43.	30	15
2003	Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int. September 2003;14(suppl 3):S13-S18.	26	26
2020	Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-Y. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. January 2020;31(1):1-12.	6	3
2020	Kanis JA, Cooper C, Rizzoli R, Reginster J-Y; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO); Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). Correction to "European guidance for the diagnosis and management of osteoporosis in postmenopausal women". Osteoporos Int. January 2020;31(1):209-209.	0	0
2020	Zürcher SJ, Borter N, Kränzlin M, Neyer P, Meyer U, Rizzoli R, Kriemler S. Relationship between bone mineral content and bone turnover markers, sex hormones and calciotropic hormones in pre- and early pubertal children. Osteoporos Int. February 2020;31(2):335-349.	0	0
2020	Bouxsein ML, Zysset P, Glüer CC, McClung M, Biver E, Pierroz DD, Ferrari SL; IOF Working Group on Hip Bone Strength as a Therapeutic Target. Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk. Osteoporos Int. March 2020;31(3):393-408.	5	4
2020	Geiker NRW, Mølgaard C, Iuliano S, Rizzoli R, Manios Y, van Loon LJC, Lecerf J-M, Moschonis G, Reginster J-Y, Givens I, Astrup A. Impact of whole dairy matrix on musculoskeletal health and aging: current knowledge and research gaps [published correction appears in Osteoporos Int. April 2020;31(4):795-795]. Osteoporos Int. April 2020;31(4):601-615.	0	0
2020	Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, Speerin R, Fujita M, Pierroz DD, Akesson K, Halbout P, Ferrari S, Cooper C. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. July 2020;31(7):1193-1204.	2	2

Name	Count	Oldest	Newest
Ferrari, Serge	8	2016	2021
Rizzoli, René	6	2003	2020